20.02.2025, 13:07

SPH Sales revenues for January 2025

Sofia, Bulgaria, February 20, 2025 – According to the requirements of Art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that for January 2025 the Company recorded an increase in sales of 7% compared to the same month of the previous year, incl. 6% increase in domestic sales and 8% increase in export sales.

Załączniki

Pobierz załącznik 1

Inne komunikaty

Data	Tytuł	Kurs	Zmiana
2025-02-20	SPH Sales revenues for January 2025	12,50	0,00
2025-02-07	SPH Minutes of the Extraordinary Generam Meeting of Shareholders of "Sopharma" AD, held on February 7, 2025	12,30	+0,41
2025-01-31	SPH Notification for a significant shareholding from CUPF Alianz Bulgaria	12,60	0,00
2025-01-30	SPH Individual financial report according to IFRS as of 31 December 2024	13,10	-3,82
2025-01-28	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for receival of shares from the capital increase of Sopharma AD	12,50	0,00
2025-01-20	SPH Sales revenues for December 2024	12,50	+8,40
2025-01-15	SPH Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212	13,75	-1,09
2025-01-02	SPH Notification from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 27 December 2024	12,25	0,00
2025-01-02	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 27 December 2024	12,25	0,00
2024-12-23	SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD	12,25	0,00

Wszystke komunikaty